Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;51(8 Suppl 3):S30-7.
doi: 10.1097/MLR.0b013e31829b1dbd.

Caveats for the use of operational electronic health record data in comparative effectiveness research

Affiliations

Caveats for the use of operational electronic health record data in comparative effectiveness research

William R Hersh et al. Med Care. 2013 Aug.

Abstract

The growing amount of data in operational electronic health record systems provides unprecedented opportunity for its reuse for many tasks, including comparative effectiveness research. However, there are many caveats to the use of such data. Electronic health record data from clinical settings may be inaccurate, incomplete, transformed in ways that undermine their meaning, unrecoverable for research, of unknown provenance, of insufficient granularity, and incompatible with research protocols. However, the quantity and real-world nature of these data provide impetus for their use, and we develop a list of caveats to inform would-be users of such data as well as provide an informatics roadmap that aims to insure this opportunity to augment comparative effectiveness research can be best leveraged.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example model of data provenance challenges associated with the identification of data related to medication administration.
Figure 2
Figure 2
Relationship between central tenets of biomedical informatics and data-centric caveats pertaining to the design and conduct of comparative effectiveness research. Solid lines indicate the primary influencers of the caveats, while the secondary influencers are indicated with dashed lines.

Similar articles

Cited by

References

    1. Blumenthal D, Tavenner M. The “meaningful use” regulation for electronic health records. New England Journal of Medicine. 2010;363:501–504. - PubMed
    1. Safran C, Bloomrosen M, Hammond WE, Labkoff SE, Markel-Fox S, Tang P, et al. Toward a national framework for the secondary use of health data: an American Medical Informatics Association white paper. Journal of the American Medical Informatics Association. 2007;14:1–9. - PMC - PubMed
    1. Weiner MG, Embi PJ. Toward reuse of clinical data for research and quality improvement: the end of the beginning. Annals of Internal Medicine. 2009;151:359–360. - PubMed
    1. Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. Journal of the American Medical Informatics Association. 2012;20:117–121. - PMC - PubMed
    1. Friedman CP, Wong AK, Blumenthal D. Achieving a nationwide learning health system. Science Translational Medicine. 2010;2(57):57cm29. http://stm.sciencemag.org/content/2/57/57cm29.full. - PubMed

Publication types

MeSH terms